Company / SG&A per Share
CG Oncology, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.95
FY2025
5-year range
$0.54 / $2.29
FY2023-FY2025
Trend
+76.4%
vs FY2024
Sector context
#122 of 210
Health Care
What the data says
At $0.95, CG Oncology, Inc.'s sg&a per share ranks #89 of 210 in the Health Care sector. Improved from $2.29 to $0.95 over the past 2 years.
Based on SEC 10-K filings.
0.95 in FY2025.
Improved from $2.29 to $0.95 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 210 in Health CareTop 42% of 210This company $0.95 Sector average $40.71
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 76.4% year-over-year.
- Ranks #122 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.95 | +76.4% |
| FY2024 | $0.54 | -76.4% |
| FY2023 | $2.29 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026